We found that expression of FGFR1 is induced by IFN-α/β and that treating HCC cells with a combination of IFN-α/β and an anti-FGFR1 mAb effectively inhibits the growth and survival of HCC cells. Here, FGFR1 is linked to hepatocellular carcinoma.